CrossrefInfokarte
Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial
Infection & Chemotherapy · 2026 · 58 (3) · 332
DOI: 10.3947/ic.2026.0016 ↗Abstract
Kein Abstract verfügbar.
EUVIMED